Skip to Content
Gregory D Kennedy, MD, PhD

Contact Dr. Kennedy

E-mail:
kennedyg@surgery.wisc.edu

Phone:
(608) 263-2521

Mail:
600 HIGHLAND AVE
BX7375 CLINICAL SCIENCE CNTR-H4
MADISON, WI 53792-3284

Gregory D Kennedy, MD, PhD

Associate Professor
Division of General Surgery
Associate Chief, Section of Colorectal Surgery
Vice Chair of Quality

Education

  • MD, University of Washington School of Medicine, Seattle, WA, 1996
  • PhD, University of Wisconsin School of Medicine and Public Health, Madison, WI, 2003
  • General Surgery Residency, University of Wisconsin School of Medicine and Public Health, Madison, WI, 1996-1998, 2003-2006
  • Colon and Rectal Surgery Fellowship, Mayo Clinic, Rochester, MN, 2006-2007

Clinical Specialties

Dr. Kennedy is certified by the American Board of Colon and Rectal Surgery and by the American Board of Surgery. In addition, he is a Fellow of the American College of Surgeons (FACS) and a Fellow of the American Society of Colon and Rectal Surgery (FASCRS). Dr. Kennedy’s main interest is in laparoscopic approaches to complex colorectal disease. He has experience with all advanced laparoscopic and minimally invasive approaches including single incision laparoscopy and robotic surgery. His clinical areas of expertise include: colon cancer, rectal cancer, inflammatory bowel disease, benign conditions of colon, rectum, and anus, and endoscopic treatment of colonic disease.

Operations that are laparoscopically performed include: sphincter preserving surgery for rectal cancer, abdominoperineal resection for rectal cancer, total and partial colon resection, restorative proctocolectomy for ulcerative colitis or prophylactically for familial cancer syndromes. Dr. Kennedy also provides the spectrum of colon and rectal surgical procedures including abscess drainage, fistulotomy, and hemorrhoidectomy.

Research Interests

Dr. Kennedy’s funded laboratory effort is focused on chemoprevention of colon and rectal cancer. His laboratory uses genetic models to better understand how chemicals prevent tumor formation and what genetic pathways are responsible for their effects. The ultimate goal of this effort is to identify targeted agents that are better tolerated by patients in hopes of preventing colon and rectal cancer.

In addition to a basic laboratory research program, Dr. Kennedy is interested in quality improvement research. His research focuses on gaining a better understanding of postoperative complications. Our hope is that by understanding the types of complications and their timing we can start to better anticipate complications and ultimately prevent them. Our prevention work uses systems approaches to improve the quality of our patient care. Through these approaches we have dropped our rate of wound complications and seen our length of stay shortened.

UW Colon and Rectal Surgery Lab

Funding/Grants

Recent Publications
  • Postoperative complications and implications on patient-centered outcomes.
    Tevis SE, Kennedy GD
    J. Surg. Res. 2013 May 1; 181(1):106-13.
    [PubMed ID: 23465392, PMC ID: 3637983]
    More Information
  • Predictors of mortality after emergent surgery for acute colonic diverticulitis: analysis of National Surgical Quality Improvement Project data.
    Ballian N, Rajamanickam V, Harms BA, Foley EF, Heise CP, Greenberg CC, Kennedy GD
    J Trauma Acute Care Surg 2013 Feb; 74(2):611-6.
    [PubMed ID: 23354259]
    More Information
  • Comparable postoperative morbidity and mortality after laparoscopic and open emergent restorative colectomy: outcomes from the ACS NSQIP.
    Ballian N, Weisensel N, Rajamanickam V, Foley EF, Heise CP, Harms BA, Kennedy GD
    World J Surg 2012 Oct; 36(10):2488-96.
    [PubMed ID: 22736343]
    More Information
  • SU5416, a VEGF receptor inhibitor and ligand of the AHR, represents a new alternative for immunomodulation.
    Mezrich JD, Nguyen LP, Kennedy G, Nukaya M, Fechner JH, Zhang X, Xing Y, Bradfield CA
    PLoS ONE 2012; 7(9):e44547.
    [PubMed ID: 22970246, PMC ID: 3435281]
    More Information
  • Identification of the Ah-receptor structural determinants for ligand preferences.
    Xing Y, Nukaya M, Satyshur KA, Jiang L, Stanevich V, Korkmaz EN, Burdette L, Kennedy GD, Cui Q, Bradfield CA
    Toxicol. Sci. 2012 Sep; 129(1):86-97.
    [PubMed ID: 22659362, PMC ID: 3491955]
    More Information

webmaster@surgery.wisc.edu Copyright © 2013 The Board of Regents of the University of Wisconsin System